Dozens of commonly prescribed drugs can make you vomit, and they do so through surprisingly different mechanisms. Chemotherapy agents, opioid painkillers, certain antibiotics, newer weight-loss medications, and even volatile anesthetics all rank among the most frequent offenders. On the other side of the coin, a few drugs are designed to induce vomiting on purpose, though medical guidelines have narrowed their use considerably over the past two decades. What unites these substances is a shared set of brain circuits and chemical messengers that the body uses to decide when it is time to empty the stomach.
How Your Body Decides to Vomit
Vomiting is coordinated by a region in the brainstem called the area postrema, sometimes referred to as the chemoreceptor trigger zone. This small patch of tissue sits on the surface of the brainstem and, unlike most of the brain, lacks a complete blood-brain barrier. That means it can directly sample whatever is circulating in your blood, functioning as a built-in poison detector.1PubMed. The area postrema and vomiting When the area postrema detects something it interprets as a toxin, it relays the signal to nearby brainstem nuclei that orchestrate the physical act of retching and vomiting.2PubMed. Nausea and the Brain: The Chemoreceptor Trigger Zone Enters the Molecular Age
Five key chemical messengers drive this system: serotonin (acting on 5-HT3 receptors), dopamine (D2 receptors), histamine (H1 receptors), acetylcholine (muscarinic receptors), and a neuropeptide called substance P (neurokinin-1, or NK1, receptors).3Anaesthesia & Intensive Care Medicine. Physiology and pharmacology of nausea and vomiting Different drugs trigger different combinations of these pathways, which is why the timing, severity, and treatability of drug-induced vomiting varies so much from one medication to the next.
Chemotherapy Drugs and the Two-Phase Assault
If you had to pick the drug class most notoriously linked to vomiting, it would be cancer chemotherapy, with cisplatin at the top of the list. Cisplatin and similar agents cause what researchers call a biphasic vomiting response. In the first few hours after infusion, the drug triggers a massive release of serotonin from specialized cells lining the gut. That flood of serotonin activates 5-HT3 receptors on the vagus nerve, which fires signals straight to the brainstem’s vomiting center. This is the acute phase.4PubMed. A re-consideration of neural/receptor mechanisms in chemotherapy-induced nausea and vomiting: current scenario and future perspective
Then, a day or more later, a second wave of nausea hits. This delayed phase is driven primarily by substance P acting on NK1 receptors in the area postrema and a neighboring structure called the nucleus tractus solitarius.4PubMed. A re-consideration of neural/receptor mechanisms in chemotherapy-induced nausea and vomiting: current scenario and future perspective Because two distinct chemical pathways are involved, no single anti-nausea drug fully controls the problem. Modern chemotherapy regimens typically pair a 5-HT3 blocker (like ondansetron) for the early phase with an NK1 blocker (like aprepitant) for the delayed phase, along with steroids and sometimes other agents. This layered approach has dramatically improved patients’ quality of life, but has not eliminated the problem entirely.
Opioid Painkillers
Nausea and vomiting are among the most common reasons people stop taking opioid painkillers like morphine, oxycodone, or codeine. The mechanism is threefold. First, opioids directly stimulate the chemoreceptor trigger zone through dopamine pathways. Second, they sensitize the vestibular system in the inner ear, which is why moving your head or standing up after taking an opioid can make the nausea dramatically worse. Third, opioids slow the muscles of the digestive tract, leading to a backup of food and gastric secretions that contributes to the sensation of nausea.5Japanese Journal of Anesthesiology. Management of opioid-induced nausea and vomiting
A common pattern with opioids is that nausea is worst during the first few days and then fades as tolerance develops. But for a meaningful number of people, the vomiting never fully goes away, especially at higher doses. This is one reason clinicians try to use the lowest effective dose and sometimes rotate between different opioids when nausea persists.
Antibiotics, Especially Erythromycin
Many antibiotics cause stomach upset, but erythromycin stands out because of its unusual mechanism. Rather than simply irritating the stomach lining, erythromycin activates a receptor in the gut called the motilin receptor, the same receptor targeted by the hormone motilin, which naturally stimulates intestinal movement.6Science Advances. Structural basis for motilin and erythromycin recognition by motilin receptor At antibiotic doses, this motilin-receptor activation causes powerful contractions that speed up stomach emptying and can provoke nausea and vomiting.7PubMed Central. Erythromycin and the gut
Here is the paradox: at much lower doses than those used to fight infections, erythromycin is actually prescribed to help people with sluggish stomach emptying. The same gut-speeding action that causes nausea at antibiotic strength becomes therapeutic at a fraction of that dose.8PubMed. Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors It is a neat illustration of how the same drug, targeting the same receptor, can produce opposite clinical effects depending on how much you take.
GLP-1 Drugs for Diabetes and Weight Loss
The explosion of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has brought a new category of drug-induced vomiting into the spotlight. Nausea and vomiting are the most frequently reported side effects of these medications, and they tend to be dose-dependent: the higher the dose, the more likely you are to feel queasy, especially during dose-escalation periods. For most people, the symptoms are transient and ease after a few weeks as the body adjusts.9Diabetes, Metabolic Syndrome and Obesity. Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations
GLP-1 drugs work partly by slowing gastric emptying, which helps control blood sugar and appetite but also means food sits in the stomach longer than usual. In rare cases, this slowing can progress to gastroparesis-like symptoms or even intestinal obstruction, though these more serious outcomes remain uncommon and the evidence around them is still mixed.9Diabetes, Metabolic Syndrome and Obesity. Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Most prescribing protocols now use a slow dose-titration schedule specifically to minimize GI side effects.
Volatile Anesthetics and Postoperative Vomiting
If you have ever woken up from surgery feeling violently nauseous, the anesthetic gas itself was likely the biggest culprit. A randomized trial comparing different volatile anesthetics found that each one massively increased the odds of vomiting in the first two hours after surgery. Isoflurane increased the odds roughly 20-fold, enflurane about 16-fold, and sevoflurane about 14.5-fold, all compared with anesthesia that avoided volatile agents altogether. There was also a clear dose-response relationship: longer exposure to the gas meant more vomiting.10BJA: British Journal of Anaesthesia. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design
Postoperative nausea and vomiting is such a widespread problem that anesthesiologists now routinely assess patients’ risk factors beforehand and pre-treat with anti-nausea medications. In some high-risk patients, they switch to total intravenous anesthesia (TIVA) to bypass volatile agents entirely.
Cannabis Hyperemesis Syndrome
Cannabis is widely known as an anti-nausea agent, which makes cannabis hyperemesis syndrome (CHS) one of the more counterintuitive drug-related vomiting conditions. In chronic, heavy users, cannabis can flip from suppressing nausea to causing relentless vomiting episodes that last hours or days. The mechanism is not completely understood, but the leading theory involves a buildup effect. With prolonged heavy use, the cannabinoid receptors in the brain and gut become desensitized. In the gut, cannabinoid stimulation normally slows stomach emptying and intestinal movement. When the brain’s anti-nausea receptors are downregulated but the gut effects persist, the balance tips toward vomiting.11PubMed Central. Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect
A hallmark of CHS is compulsive hot bathing: patients often report that only extremely hot showers or baths provide temporary relief. This peculiar feature, along with the paradox of an antiemetic substance causing emesis, helps distinguish CHS from other causes of cyclic vomiting. The condition tends to resolve when cannabis use stops entirely.12PubMed Central. Cannabis hyperemesis syndrome: an update on the pathophysiology and management
Zinc and Other Over-the-Counter Emetogens
Not all drugs that cause vomiting are prescription medications. Zinc supplements, recommended by the World Health Organization for children with acute gastroenteritis, frequently cause vomiting at standard doses due to direct irritation of the stomach lining. High elemental zinc doses of 20 mg per day cause emesis in a significant proportion of children, leading some researchers to suggest switching to lower doses that may maintain therapeutic benefit with less vomiting.13PubMed Central. Oral zinc-induced vomiting in children with acute gastroenteritis. Should we switch to low-dose zinc? Iron supplements are another well-known offender, particularly when taken on an empty stomach. Large doses of vitamin C and nonsteroidal anti-inflammatory drugs like ibuprofen can also provoke nausea and vomiting, especially in sensitive individuals, through direct irritation of the gastric mucosa.
Drugs Designed to Make You Vomit
For most of medical history, inducing vomiting was considered a frontline treatment for poisoning. The two most prominent intentional emetics are ipecac syrup and apomorphine, and both have seen their clinical roles shrink considerably.
Ipecac syrup, once a staple of home medicine cabinets and emergency departments, works by irritating the stomach and stimulating the chemoreceptor trigger zone. But evidence accumulated showing that the amount of poison actually removed by ipecac-induced vomiting was highly variable and declined quickly over time. More critically, no clinical studies demonstrated that using ipecac improved outcomes for poisoned patients. On top of that, giving ipecac could delay the use of more effective treatments like activated charcoal or oral antidotes. The expert consensus now is that routine ipecac use in poisoning cases should be abandoned.14Clinical Toxicology. Position paper: Ipecac syrup
Apomorphine, a potent dopamine agonist, triggers vomiting by directly stimulating D2 receptors in the chemoreceptor trigger zone. Research in animals showed that injecting apomorphine directly into the brain required a dose 30 to 50 times lower than the intravenous route to trigger emesis, confirming that its emetic action is centrally mediated.15European Journal of Pharmacology. Central mechanisms for apomorphine-induced emesis in the dog In veterinary medicine, apomorphine remains a go-to emetic for dogs that have swallowed something toxic, while xylazine is preferred in cats.16PubMed. Zehirlenmelerde Genel İlk Yardım ve Tedavi Yaklaşımları In human medicine, apomorphine is no longer used to induce vomiting but has found a second life as a treatment for Parkinson’s disease, where its dopamine-stimulating properties are the desired effect and nausea is managed as a side effect.
Colchicine and Dose-Dependent Toxicity
Some drugs cause vomiting only when their dose crosses a toxic threshold. Colchicine, used for gout and certain inflammatory conditions, is a good example. At therapeutic doses, GI symptoms like nausea and diarrhea are common but manageable. In overdose, colchicine toxicity presents with severe abdominal pain, along with rhabdomyolysis and dangerously low white blood cell counts.17PubMed Central. A Case of Colchicine Overdose and Toxicity The narrow gap between a therapeutic dose and a toxic one makes colchicine particularly risky, and intractable vomiting is often an early warning sign that the dose has gone too far. Digoxin, a heart medication, follows a similar pattern: nausea and vomiting are classic signals of toxicity rather than routine side effects.
When Vomiting Starts Before the Drug Does
One of the stranger phenomena in drug-induced vomiting has nothing to do with pharmacology at all. Patients undergoing repeated chemotherapy cycles can develop what is called anticipatory nausea and vomiting, where the nausea kicks in before any drug enters their body. This can happen on the car ride to the clinic, in the waiting room, or even at the smell of the hospital. The mechanism is classical conditioning: the brain has paired the sights, smells, and contexts of treatment with the post-treatment sickness, and eventually those cues alone are enough to trigger the response.18PubMed Central. Anticipatory nausea and vomiting due to chemotherapy
Roughly a quarter of chemotherapy patients experience anticipatory nausea at any given cycle, and the proportion climbs to about 25 to 30 percent by the fourth cycle.19PubMed Central. Anticipatory nausea and vomiting The best approach is prevention: keeping post-treatment nausea well controlled with antiemetics from the start reduces the conditioning that leads to anticipatory symptoms. Once established, anticipatory nausea is frustratingly resistant to standard anti-nausea drugs, because the problem is not chemical but learned. Behavioral interventions like desensitization and relaxation techniques are more effective than medication at that point.
Why Some People Vomit More Than Others
If two people take the same drug at the same dose and one gets violently ill while the other feels nothing, genetics is part of the explanation. Research into postoperative nausea and vomiting has identified specific gene variants that influence susceptibility. Variations in the CYP2D6 gene, which affects how quickly the body metabolizes certain drugs, and in the OPRM1 gene, which encodes an opioid receptor, appear to play a role. People who carry a particular variant of the OPRM1 gene (the G-allele from the A118G polymorphism) seem to be somewhat protected against postoperative vomiting, while those with ultrarapid CYP2D6 metabolism face higher risk.20PubMed. Pharmacogenetics of Postoperative Nausea and Vomiting
The genetic picture extends beyond these two genes. Studies have found associations with dopamine receptor genes, acetylcholine receptor genes, and drug-transporter genes, suggesting that susceptibility to nausea is genuinely multifactorial. The tendency for postoperative vomiting to run in families, and the strong concordance seen in identical twins, reinforces the idea that your baseline nausea sensitivity is at least partly inherited.21PubMed. Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomiting Sex is another well-established factor: women are roughly two to three times more likely than men to experience postoperative nausea, probably reflecting hormonal influences on the same pathways. Non-smokers also tend to be more susceptible than smokers, for reasons that remain somewhat unclear.
How Understanding Emesis Led to Better Anti-Nausea Drugs
The same neurotransmitter pathways that explain why drugs cause vomiting have been reverse-engineered to produce better treatments for it. The development of 5-HT3 receptor antagonists like ondansetron in the early 1990s was a turning point for chemotherapy patients, drastically reducing acute-phase vomiting. The next major advance came with NK1 receptor antagonists, which target the substance P pathway responsible for delayed vomiting. Early trials showed that adding an NK1 blocker to existing anti-nausea regimens improved control of both the acute and delayed phases of chemotherapy-induced vomiting.22PubMed. Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development The recognition that substance P plays a central role in the brain’s emetic circuitry drove the creation of this entire drug class.23British Journal of Anaesthesia. Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting
These antiemetics are now used well beyond oncology. NK1 blockers are part of standard postoperative nausea protocols, and newer combination drugs that bundle a 5-HT3 blocker with an NK1 blocker in a single capsule have simplified dosing. The principle is always the same: because vomiting involves multiple chemical pathways working in parallel, the most effective strategy is to block more than one at the same time.
Animals That Cannot Vomit at All
Not every species even has the ability to vomit, and this matters more than you might think. Rodents, the animals most commonly used in biomedical research, are generally unable to vomit. They lack the brainstem circuitry that generates the coordinated pattern of muscle contractions needed for emesis, and their anatomy presents structural barriers at the junction between the esophagus and stomach that make retrograde movement of stomach contents extremely difficult.24PubMed Central. Why Can’t Rodents Vomit? A Comparative Behavioral, Anatomical, and Physiological Study
While there has been occasional published evidence of retching-like behavior in rats, genuine vomiting in rodents remains unproven after roughly a century of observation.25PubMed Central. Emesis in Rodents: Present or Absent? A Critical Review of the Evidence and Implications for the Use of Rodents in Biomedical Research This poses a real problem for drug development. If your primary lab animal cannot vomit, you can miss emetic side effects entirely during preclinical testing. Researchers studying nausea and vomiting often turn to other species, such as ferrets or shrews, that retain a functional vomiting reflex. The rodent limitation is one reason why some drugs reach human trials with unexpectedly high rates of nausea: the animals used to test them simply could not report the problem.